Expression of CD44 Mrna in Human Colorectal Tumors

Wan Yuanlian

1999-01-01

Abstract:Objective To test the expression of CD44 gene in colorectal polyps, cancers in contrast to that of normal mucosae, and investigate its importance in the progression and metastasis of colorectal tumors. Methods The expression of CD44 mRNA was examined in cancerous tissues and adjacent noncancerous mucosae from 26 patients with colorectal cancer and in colorectal polyps from 7 patients by reverse transcription polymerase chain reaction and Southern blot hybridization. Results Strong expression of the epithelial form and variant forms containing variant exon 6 or 10 of the CD44 gene was detected in polyps and cancerous tissues, whereas it was very weak or not detectable in normal colonic mucosae. Significant correlations were not observed between the epithelial variant/hematopoietic variant (E/H) ratio and clinical features( t test, P 0 05). The E/H ratio was 1 4±1 0 in Dukes' stages A and B compared with 1 4±0 9 in stages C and D. The E/H ratio was 1 6±1 0 in cancers infiltrating to muscular layer compared with 1 3±0 9 in cancers infiltrating through the colonic wall. The E/H ratio was 1 4±1 0 in cancers with metastasis compared with 1 40±1 05 in cancers without metastasis. Conclusions Expression of CD44 epithelial forms was significantly higher in colorectal tumor tissue than in matched normal mucosa. CD44 variant forms were expressed in an early stage of colorectal tumorgenesis. Variant forms sharing exon V6 or V10 may play a role in colorectal tumorgenesis and progression. The clinical value of E/H ratio in colorectal cancer needs further elucidation.